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RESUMEN 
Cafeína y función biológica de los receptores de adenosina 
 
Hace aproximadamente 30 años se descubrió que la cafeína, la más empleada de todas 
las substancias psico-estimulantes, es capaz de antagonizar los efectos de la adenosina a 
concentraciones que se alcanzan durante el consumo normal de café y otros alimentos ó 
bebidas. Este descubrimiento tiene varias consecuencias importantes: 1) existen 
receptores para los cuales la adenosina es el agonista y la cafeína el antagonista; 2) Ya 
que el antagonista es biológicamente activo, los receptores deben de estar activados por 
la adenosina endógena. Esta breve visión de conjunto, la cual refleja el contenido del 
Discurso de Entrada en la Real Academia de Farmacia del Profesor B. Fredholm, 
presentará los datos que avalan las conclusiones previamente enunciadas. 
El metabolismo de la adenosina y sus niveles en condiciones normales y fisiopatológicas 
es conocido con detalle. Actualmente han sido clonados y caracterizado farmacologi-
camente cuatro receptores de adenosina. Todos ellos están acoplados a proteínas G y 
tienen cascadas de señalización y distribuciones diversas en el organismo. Es probable 
que los efectos biológicos de la cafeína se realicen mayoritariamente a través de 
receptores A1 y A2A. Los datos obtenidos con ratones genéticamente modificados, 
anulando estos genes confirma su función biológica. 
Palabras clave: Cafeína. Enfermedad de Parkinson. Factores CREB. Nucleo 
estriado Neuronas GABAergicas. Proteinas G. Receptores de adenosina. 
Receptores de dopamina. 
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SUMMARY 
Caffeine and the biological role of adenosine receptors 
 
About thirty years ago it was realized that caffeine, the most widely used of all 
psychoactive drugs, is able to antagonize the effects of adenosine at concentrations 
achieved during normal human consumption. This finding had several important 
implications: 1) there are receptors at which adenosine is the agonist and caffeine the 
antagonist; 2) since the antagonist is biologically active it should mean that the receptors 
are activated by endogenous adenosine. This brief overview, which reflects the contents 
of my introductory lecture at the Academy, will present some data vindicating these 
conclusions. 
The metabolism of adenosine and its levels under normal and pathophysiological 
conditions has been elucidated. Now four different adenosine receptors have been cloned 
and pharmacologically characterized. They are all G protein coupled. Their different 
signalling characteristics are briefly summarized as is their distribution. Based on these 
data t is concluded that caffeine probably exerts its effects by blocking adenosine A1 and 
A2A receptors. The biological role(s) of these receptors is finally presented using data 
from knock-out mice. 
Key words: Cafeine. Parkinson's disease. CREB factors. Striatum. 
GABAergic neurons. G proteins. Adenosine receptors. Dopamine receptors. 
 
About thirty years ago it was realized, from the work of i.a. Ted 
Rall and John Daly, that caffeine, the most widely used of all 
psychoactive drugs, is able to antagonize the effects of adenosine at 
concentrations achieved during normal human consumption (see 
Fredholm; 1980). This finding had several important implications: 1) 
there are receptors at which adenosine is the agonist and caffeine the 
antagonist; 2) since the antagonist is biologically active it should mean 
that the receptors are activated by endogenous adenosine. This brief 
overview, which reflects the contents of my introductory lecture at the 
Academy, will present some of the data from my own laboratory 
vindicating these conclusions. The interested reader is referred to other 
more compendious reviews (Ferré, Fredholm, Morelli, Popoli and Fuxe; 
1997, Fredholm, Bättig, Holmén, Nehlig and Zvartau; 1999, 
Svenningsson, Le Moine, Fisone and Fredholm; 1999, Fredholm, 
IJzerman, Jacobson, Klotz and Linden; 2001, Fredholm; 2002, 
Svenningsson and Fredholm; 2002, Fredholm and Svenningsson; 2002 
Submitted, Fredholm, Cunha and Svenningsson; 2003). I also need to 
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point out that the extremely important contributions by other scientists 
will not be covered here. 
 
Regulation of the levels of adenosine 
It should be clearly understood that adenosine does not act as a 
classical hormone or neurotransmitter: it is not stored in vesicles, it is not 
released by exocytosis, it does not appear to transfer information from the 
pre- to the postsynaptic components and it does not act only or 
predominantly in synapses. Instead, adenosine fulfils a double role (see 
Cunha; 2001a), acting both as a homeostatic trans-cellular messenger, and 
as a modulator, controlling i.a. neurotransmitter release and neuronal 
excitability.  
Adenosine can appear in the extracellular milieu through three 
different mechanisms: 1) the release of adenosine as such through 
nucleoside transporters upon increase of the intracellular levels of 
adenosine; 2) the extracellular formation of adenosine through the ecto-
nucleotidase pathway on release of adenine nucleotides, and 3) the 
extracellular formation of adenosine on release of cAMP (reviewed in 
Dunwiddie and Masino; 2001). The third pathway has been found to be of 
minor importance in more integrated preparations when physiological 
parameters affected by adenosine are being studied (Brundege, Diao, 
Proctor and Dunwiddie; 1997).  
The idea that adenosine is mostly released as such through the 
different classes of nucleoside transporters is probably the most popular 
hypothesis. It was formulated essentially by analogy with the way 
extracellular adenosine is generated upon cytotoxic insults, like hypoxia 
or metabolic poisoning (for references, see Cunha; 2001a, Dunwiddie and 
Masino; 2001, Latini and Pedata; 2001). In stressful situations, there is an 
imbalance between energy supply and demand, leading to a net hydrolysis 
of ATP. Via a series of steps, this ATP is converted to adenosine, leading 
to a dramatic increase in the intracellular concentration of adenosine, 
which, at rest, is around 50 nM. The presence of non-concentrative bi-
directional adenosine transporters will then force extracellular adenosine 
to rise in parallel with intracellular adenosine. Given that intracellular 
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ATP levels are some 100,000 times higher, it is obvious that substantial 
changes in adenosine levels can occur without any major changes in ATP 
levels. Indeed, extracellular adenosine can be formed without any 
measurable change in the energy status of CNS preparations (Mitchell, 
Lupica and Dunwiddie; 1993, Doolette; 1997). Given that the energy 
demanded  and hence the utilization of ATP  is substantial in localized 
neuronal compartments as a consequence of work needed to maintain ion 
balance, it is clear that substantial local adenosine formation could occur 
via this mechanism. Nevertheless, it is difficult to explain the time course 
of extracellular adenosine build-up, which may become sufficient to 
modulate synaptic transmission in less than 20 ms (Mitchell et al.; 1993), 
a time course much lower than the Kcat of most enzymes and adenosine 
transporters. Also, this release of adenosine through nucleoside 
transporters is at odds with the ability of inhibitors of nucleoside transport 
to potentiate the effects of endogenous adenosine (for references, see 
Cunha; 2001a, Latini and Pedata; 2001), which indicates that the role of 
nucleoside transporters is mostly to clear up rather than to mediate 
adenosine release, at least in non-stressful situations. Nevertheless, and as 
discussed previously, this finding may be explained if in any 
compartment there are cells that produce adenosine, and others that 
release itsee (Fredholm, Lindström and Wallman-Johansson; 1994).  
The last hypothesis concerning the origin of extracellular 
adenosine is based on the extracellular catabolism of released adenine 
nucleotides, mainly of released ATP, through the ecto-nucleotidase 
pathway (for reviews, see Zimmermann; 2000, Cunha; 2001b). In fact, in 
contrast to adenosine, ATP is present in synaptic vesicles and the 
vesicular release of ATP on stimulation of nerve terminals is well 
documented (see references in Cunha; 2001a). However, only a few 
studies have so far gathered direct evidence for the role of ecto-
nucleotidases in forming extracellular adenosine (see references in Cunha; 
2001a-b). This might be due to the difficulty to block completely an 
enzyme system that is extremely efficient and where the spatial 
relationship between enzyme and effector system is very close 
(Dunwiddie, Diao and Proctor; 1997, Cunha, Sebastião and Ribeiro; 
1998, Cunha; 2001b). It should also be pointed out that neurochemical 
studies have concluded that the extracellular adenosine, which is relevant 
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for modulation of synaptic transmission, might originate not only from 
nerve terminals but also from the activated postsynaptic component  (see 
references in Cunha; 2001a, Dunwiddie and Masino; 2001, Latini and 
Pedata; 2001) as well as from surrounding non-neuronal cells. Both 
astrocytes and dendritic compartments are apparently devoid of a fast 
exocytotic apparatus and yet they are also able to release ATP (Caciagli, 
Ciccarelli, Di Iorio, Ballerini and Tacconelli; 1988) by a mechanism 
largely unknown (Bodas, Aleu, Pujol, Martin-Satué, Marsal and Solsona; 
2000, Bodin and Burnstock; 2001).  
Thus, there are several mechanisms that contribute to the 
formation of extracellular adenosine. And most importantly, it should be 
stressed that to understand how adenosine is released, one needs to keep 
in mind that different stimuli will trigger different ways of generating 
extracellular adenosine. Figure 1 schematically represents the possible 
contributions of the different compartments in the CNS to control the 
extracellular levels of purines.  
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In contrast, the clearance of extracellular adenosine is better 
understood. It mostly occurs through the action of the non-concentrative 
adenosine transporters, and the effectiveness of the uptake system is 
guaranteed by the efficient intracellular metabolisation of adenosine. 
Indeed, adenosine can either be converted into inosine through adenosine 
deaminase or be phosphorylated into AMP via adenosine kinase. The 
comparison of the kinetic parameters of each of the enzymes lead to the 
proposal that adenosine kinase was the initial pathway to salvage 
intracellular adenosine, with adenosine deaminase only coming to play 
when large amounts of adenosine have to be cleared. This is confirmed by 
the general greater effectiveness of adenosine kinase inhibitors to increase 
the extracellular levels of adenosine under physiological situations and 
the increased effectiveness of adenosine deaminase inhibitors to increase 
the extracellular levels of adenosine with increased neurotoxic insults. 
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FIGURE 1. Schematic representation of the mechanisms by which adenosine levels are 
regulated. 
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This probably reflects the relative importance of neuronal versus non-
neuronal uptake of adenosine since the two enzymatic activities have 
apparently different cellular locations with adenosine kinase being 
enriched in neurons and adenosine deaminase being more abundant in 
astrocytes  It should also be mentioned that adenosine can also be 
extracellularly deaminated into its inactive metabolite inosine through an 
ecto-adenosine deaminase (Franco, Casadó, Ciruela, Saura, Mallol, 
Canela and Lluis; 1997), although the relevance of this pathway for 
adenosine clearance in the CNS remains to be established (Cunha; 
2001b).  
An alternative pathway for intracellular metabolization of 
adenosine would be via the S-adenosylhomocysteine pathway. But 
although this pathway is of relevance for the control of intra- and 
extracellular levels of adenosine in cardiomyocytes for instance, it 
appears to be of limited importance in the nervous system. 
The balance between the effectiveness of releasing and clearing up 
adenosine will give raise to a transient extracellular build up of adenosine. 
However, the presumably different location of release sites and uptake 
sites makes it difficult to estimate an extracellular concentration of 
adenosine since one should instead discuss the amplitude of extracellular 
adenosine gradient. Pharmacological manipulation of the activity of 
adenosine transporters and adenosine receptor responses have lead to an 
estimate of the transient concentration of adenosine facing A1 receptors 
between 200-400 nM in the rat brain (Dunwiddie and Diao; 1994). This 
estimate of an effective concentration of adenosine is similar to those 
found in microdialysis studies without stimulating or insulting the CNS 
(Hagberg, Andersson, Lacarewicz, Jacobson, Butcher and Sandberg; 
1987). Upon stimulation (During and Spencer; 1992) or upon stressful 
conditions (Hagberg et al.; 1987) the extracellular amounts of adenosine 
can build up to tenths of micromolar.  
Adenosine receptors  
Despite the fact that adenosine receptors were well characterized 
and partially purified the two first adenosine receptors cloned, A1 and 
A2A, came from a library of orphan receptors from the dog thyroid 
(Maenhaut, Van Sande, Libert, Abramowicz, Parmentier, Vanderhaegen, 
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Dumont, Vassart and Schiffmann; 1990, Libert, Schiffmann, Lefort, 
Parmentier, Gerard, Dumont, Vanderhaeghen and Vassart; 1991). Soon 
the same receptors were cloned from rat and humans (Mahan, McVittie, 
Smyk-Randall, Nakata, Monsma Jr, Gerfen and Sibley; 1991, Furlong, 
Pierce, Selbie and Shine; 1992), and a related receptor, the A2B receptor, 
was cloned from rat brain (Stehle, Rivkees, Lee, Weaver, Deeds and 
Reppert; 1992). These receptors had all been predicted from extensive 
pharmacological studies. The fourth receptor, A3, was more unexpected. 
By now these four adenosine receptors have been cloned from several 
mammalian and non-mammalian species. A1, A2A and A2B receptors are 
well conserved among mammals, but A3 receptors show considerable 
structural variability.  
For all four adenosine receptors the coding region is split up by an 
intron in a region corresponding to the second intracellular loop 
(Fredholm, Arslan, Halldner, Kull, Schulte and Wasserman; 2000). 
Already when the structure of the A1 receptor was first reported the 
presence of two major transcripts was noted. Transcripts containing three 
exons, called exons 4, 5 and 6 were found in all tissues expressing the 
receptor, whereas transcripts containing exons 3, 5 and 6 are in addition 
found in tissues such as brain, testis and kidney, that express high levels 
of the receptor (Ren and Stiles; 1994, 1995). There are two promoters, a 
proximal one denoted promoter A, and a distal one denoted promoter B, 
which are about 600 bp apart. The 5-untranslated region of the adenosine 
A2A receptor gene also displays two alternative promoters, although it 
lacks the diversity of exons found in the A1 receptor gene (Chu, Tu, Lee, 
Kuo, Lai and Chern; 1996, Lee, Chang, Su, Lin, Sun, Lai and Chern; 
1999). The A2A receptor shows one hybridizing transcript in most tissues 
examined (Stehle et al.; 1992, Ren and Stiles; 1994, 1995). The rat A2B 
receptor shows two hybridizing transcripts of 1.8 and 2.2 kb, where the 
latter is the dominant one (Stehle et al.; 1992). This could, in analogy 
with the above, suggest the presence of multiple promoters. The human 
A3 receptor shows two transcripts: the most abundant is approximately 2 
kb in size, and the less abundant one about 5 kb (Atkinson, Townsend-
Nicholson, Nicholl, Sutherland and Schofield; 1997), perhaps indicating 
similarities with the A1 receptor gene. 
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The distribution of receptors tells us where agonists and 
antagonists given to the intact organism can act. Furthermore, the rather 
low levels of endogenous adenosine present under basal physiological 
conditions have the potential of activating receptors where they are 
abundant, but not where they are sparse (Svenningsson, Nomikos and 
Fredholm; 1999). 
There is much information on the distribution of the A1 and A2A 
receptors from several different species, because good pharmacological 
tools including radioligands (see below) are available. There are also 
several studies that have used antibodies to localize adenosine A1 and A2A 
receptors receptors in brain (Rosin, Robeva, Woodard, Guyenet and 
Linden; 1998, Hettinger, Lee, Linden and Rosin; 2001). In the case of the 
A2B and A3 receptors the data are less impressive. Here one tends to rely 
on data on the expression of the corresponding mRNA. Some of this 
information is summarized in Table 1. 
Adenosine A1 receptor mRNA is widespread in the brain, with the 
highest levels in cell bodies in hippocampus, cerebellum and cerebral 
cortex (Mahan et al.; 1991, Reppert, Weaver, Stehle and Rivkees; 1991). 
Studies using immunohistochemistry and ligand autoradiography have 
shown that adenosine A1 receptor protein and the corresponding mRNA 
do not exactly match in several regions of the central nervous system 
(Johansson, Ahlberg, van der Ploeg, Brené, Lindefors, Persson and 
Fredholm; 1993, Swanson et al.; 1995). Much of the differential 
distribution can probably be explained by the fact that a substantial 
number of adenosine A1 receptors are present at nerve terminals. For 
example, a careful examination of the comparative distribution of 
adenosine A1 receptor mRNA and protein in hippocampus showed that 
this mRNA is enriched in cell bodies in the granular layer of dentate 
gyrus and the pyramidal layers of CA1 and CA3, whereas [3H]DPCPX 
binding and A1 receptor immunoreactivity is predominantly found in the 
dentate hilus stratum moleculare, stratum lacunosum, stratum radiatum 
and stratum oriens (Swanson et al.; 1995). Double immunofluorescence 
experiments showed that A1 receptor protein co-localize with SMI-31 that 
labels axons, but to a lesser extent with MAP2a, b, which labels cell 
bodies and dendrites, or with synaptophysin, which labels synapses. 
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Interestingly, the levels of adenosine A1 receptor mRNA and protein are 
differently regulated by, e.g., long term antagonist treatment (Johansson, 
Ahlberg, van der Ploeg, Brené, Lindefors, Persson and Fredholm; 1993) 
and during development (Ådén, Herlenius, Tang and Fredholm; 2000). 
The general distribution of adenosine A1 receptors is similar between 
rodents and humans (Fastbom, Pazos and Palacios; 1987, Svenningsson, 
Hall, Sedvall and Fredholm; 1997, Schindler, Harris, Hayes, Papotti and 
Humphrey; 2001). Initial attempts to localize adenosine A1 receptors in 
the living brain using [11C]KF15372 and [11C]MPDX and positron 
emission tomography (PET) have been made (Noguchi, Ishiwata, Furuta, 
Simada, Kiyosawa, Ishii, Endo, Suzuki and Senda; 1997, Shimada, 
Ishiwata, Kiyosawa, Nariai, Oda, Toyama, Suzuki, Ono and Senda; 
2002).  
Adenosine A2A receptor mRNA is highly enriched in the striatum 
(Schiffmann, Libert, Vassart and Vanderhaeghen; 1991, Fink, Weaver, 
Rivkees, Peterfreund, Pollack, Adler and Reppert; 1992, Svenningsson, 
Hall, Sedvall and Fredholm; 1997). Lower levels are also found in 
extrastriatal areas, such as lateral septum, cerebellum, cortex and 
hippocampus  (Dixon, Gubitz, Sirinathsinghji, Richardson and Freeman; 
1996, Svenningsson, Hall, Sedvall and Fredholm; 1997). Most striatal 
neurons (95%) are GABAergic projection neurons. These neurons can be 
divided into two major subtypes based on their target areas and 
neuropeptide contents. One sub-population projects to globus pallidus and 
contain enkephalin. Another sub-population projects to substantia nigra 
pars reticulata/the entopeduncular nucleus and contains substance P and 
dynorphin. Interestingly, adenosine A2A receptors are selectively 
expressed in the enkephalin-containing striatopallidal neurons 
(Schiffmann, Libert, Vassart and Vanderhaeghen; 1991, Fink et al.; 1992, 
Augood and Emson; 1994, Svenningsson, Hall, Sedvall and Fredholm; 
1997). In addition to the GABAergic projection neurons, there are also 
cholinergic and GABAergic interneurons in striatum. It is still 
controversial whether these interneurons contain adenosine A2A receptors. 
Studies using in situ hybridization have been unable to detect adenosine 
A2A receptor mRNA in interneurons (Schiffmann, Libert, Vassart and 
Vanderhaeghen; 1991, Augood and Emson; 1994, Svenningsson, Hall, 
Sedvall and Fredholm; 1997). However, a single cell PCR study detected 
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adenosine A2A receptor mRNA in cholinergic interneurons (Richardson, 
Dixon, Lee, Bell, Cox, Williams, Pinnock and Freeman; 2000). 
Studies using immunohistochemistry and ligand autoradiography 
show high levels of adenosine A2A receptors in all sub-regions of striatum 
(Jarvis and Williams; 1988, Parkinson and Fredholm; 1990, Rosin et al.; 
1998). In addition, high levels of adenosine A2A receptors have also been 
found in globus pallidus. These receptors are located on nerve terminals 
from the striatal projection neurons which innervate globus pallidus 
(Rosin et al.; 1998).  Using A2A receptor-selective antibodies and 
immunohistochemistry at the light- and electron-microscopic levels, 
Rosin and her colleagues (Rosin et al.; 1998, Hettinger et al.; 2001) have 
shown that striatal adenosine A2A receptors are found in most neuronal 
compartments, i.e. dendrites, terminals of axon collaterals and in soma. 
However, the highest levels are found in dendrites and dendritic spines 
that form asymmetric synapses. These synapses receive input from 
glutamatergic terminals and are of excitatory nature. This postsynaptic 
localization of A2A receptors implies that A2A receptors may play an 
important role in the regulation of synaptic plasticity. Indeed, a functional 
correlate to this anatomical finding has recently been demonstrated, 
namely that NMDA receptor-dependent long-term potentiation in the 
nucleus accumbens is significantly attenuated by selective A2A receptor 
antagonists or in A2A receptor KO mice (d'Alcantara, Ledent, Swillens 
and Schiffmann; 2001). 
The distribution of adenosine A2A receptors is similar in rodents 
and humans (Martinez-Mir, Probst and Palacios; 1991, Schiffmann, 
Libert, Vassart and Vanderhaeghen; 1991). However, the levels of 
extrastriatal adenosine A2A receptors appear to be higher in humans than 
in rodents. Since there is accumulating evidence for a critical role of 
adenosine A2A receptors in the pathophysiology of several neurological 
and psychiatric disorders, most notably Parkinsons disease and 
schizophrenia, it will be of great interest to be able to monitor the levels 
of adenosine A2A receptors in the living brain using PET. There are 
several reports about various ligands, including [11C]KW-6002, [11C]IS-
DMPX, [11C]KF 18446 and [11C]KF 17837 (Stone-Elander, Thorell, 
Eriksson, Fredholm and Ingvar; 1997, Ishiwata, Noguchi, Wakabayashi, 
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Shimada, Ogi, Nariai, Tanaka, Endo, Suzuki and Senda; 2000, Hirani, 
Gillies, Karasawa, Shimada, Kase, Opacka-Juffry, Osman, Luthra, Hume 
and Brooks; 2001). However, these PET ligands do not appear ideal since 
non-specific, extrastriatal binding is high.  
Biochemical studies have demonstrated low levels of adenosine 
A2B receptors on most neurons and glia cells and in situ hybrization 
studies specifically demonstrated the presence of adenosine A2B receptor 
mRNA in the hypophyseal pars tuberalis (Stehle et al.; 1992). The levels 
of A3 receptors in the brain are also low, but there appear to be species 
differences, with the levels being higher sheep and humans than in 
rodents (Salvatore, Jacobson, Taylor, Linden and Johnson; 1993). 
Signaling via Adenosine Receptors 
The adenosine A1 and A2 receptors were initially subdivided on the basis 
of their ability to inhibit and stimulate adenylyl cyclase, respectively 
(Londos, Cooper and Wolff; 1980). Indeed, A1 and A2 receptors are 
coupled to members of the Gi group and Gs group of G proteins, 
respectively (Table 1). 
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 Adenosine A1 receptor Adenosine A2A receptor Adenosine A2B receptor Adenosine A3 receptor 
Previous/Alternative 
names 
Ri ; AA1R A2a, Rs; AA2AR A2b, Rs; AA2BR AA3A 
Selective agonists CPA, CCPA, CHA CGS 21680, HE-NECA, CV-
1808, CV-1674, ATL146e 
None Cl-IB-MECA 
Selective antagonists DPCPXa 8-cyclopentyl-
theophylline, WRC0571 
selective: SCH 58261f,g 
moderately selective: 
ZM241385a, KF 17387, CSC 
MRS1754j, enprofylline MRS 1220, MRE 3008-F20, 
MRS 1191; MRS 1523 
Radioligands [3H]-DPCPX; [3H]-CHA [3H]-CGS 21680; [3H]-SCH 
58261; [3H]-ZM-241385 
([3H]-ZM-241385; [3H]-
DPCPX) 
[3H]-MRS1754 
[3H]- MRE 3008-F20 
Antibodies Several commercial and non-
commercial peptide antibodies 
Several commercial and non-
commercial peptide 
antibodies; 
Some commercial and non-
commercial peptide antibodies 
Some commercial and non-
commercial peptide antibodies 
Structural information 
(Accession numbers) 
Human 326 aa, P30542, , rat 326 
aa, P25099, 
Human 410 aa, P29274, rat 
409 aa, P30543, mouse 409 
aa, UO5672 
Human 328 aa, P29275, rat 
332 aa, P29276 mouse 332 aa, 
UO5673 
Human 318 aa, P33765, rat 320 
aa P28647(Alternative splicing in 
rat can yield product with 337 aa) 
Mouse 320 aa, AF069778 
G protein coupling Gi, Go Gs, Golf Gs, Gq  Gi 
Expression pattern in 
nervous system. 
High expression: 
Brain (cortex, cerebellum, 
hippocampus). Dorsal horn of 
spinal cord. Eye, adrenal gland 
Intermediate levels: 
Other brain regions.  
High expression:  
Striatopallidal GABAergic 
neurons (in caudate-putamen, 
nucleus accumbens, 
tuberculum olfactorium), 
olfactory bulb 
Low levels:Rest of brain 
Intermediate levels: 
Blood vessels, eye, median 
eminence, mast cells 
(human?) 
Low levels: Adrenal gland, 
pituitary gland 
Intermediate levels: Cerebellum 
(human?), hippocampus 
(human?) 
Low levels: Most of brain (rat, 
mouse).  
Gene name/chromosomal 
location 
chr 1q32.1 chr 22g11.2 chr 17p11.2-12; chr 1p21-13, 
Main physiological 
function(s) 
Bradycardia; inhibition of 
lipolysis; reduced glomerular 
filtration; tubero-glomerular 
feedback, antinociception; 
Regulation of sensorimotor 
integration in basal ganglia; 
inhibition of platelet 
aggregation and 
Relaxation of smooth muscle 
in vasculature and intestine; 
inhibition of monocyte and 
macrophage function, 
Enhancement of mediator release 
from mast cells (some species). 
Preconditioning (some species). 
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reduction of sympathetic and 
parasympathetic activity; 
presynaptic inhibition; neuronal 
hyperpolarization; ischemic 
preconditioning. 
polymorphonuclear 
leukocytes; vasodilatation, 
protection against ischemic 
damage, stimulation of 
sensory nerve activity. 
stimulation of mast cell 
mediator release (some 
species). 
Knockout phenotype Anxiety, hyperalgesia, decreased 
tolerance to hypoxia, loss of 
tubero-glomerular feedback 
Anxiety, hypoalgesia, 
hypertension, increased 
tolerance to ischemia, altered 
sensitivity to motor stimulant 
drugs, decreased platelet 
aggregation.  
 Altered inflammatory reactions, 
decreased edema, altered release 
of inflammatory mediators. 
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The A3 receptor is also Gi coupled. In addition, there is some 
evidence from transfection experiments that the adenosine receptors may 
signal via other G proteins, but it is not known if such coupling is 
physiologically important. Recently, evidence was presented that whereas 
the A2A receptor is coupled to Gs in most peripheral tissues it is coupled to 
Golf in striatum (Kull, Svenningsson and Fredholm; 2000). Endogenous 
A2B receptors of HEK 293 cells, human HMC-1 mast cells and canine BR 
mast cells may be dually coupled to Gs and Gq  
After activation of the G proteins, enzymes and ion channels are 
affected as can be predicted from what is known about G protein 
signaling. Thus, A1 receptors mediate inhibition of adenylyl cyclase, 
activation of several types of K+-channels (probably via ,-subunits), 
inactivation of N, P and Q-type Ca2+ channels, activation of 
phospholipase C etc. The same appears to be true for A3 receptors. In 
CHO cells transfected with the human adenosine A3 receptor both 
adenylyl cyclase inhibition and a Ca2+ signal are mediated via a Gi/o-
dependent pathway. Given that many of the steps in the signaling cascade 
involve signal amplification it is not surprising that the position of the 
dose-response curve for agonists will depend on which particular effect is 
measured Both A2A and A2B receptors stimulate the formation of cAMP, 
but other actions, including mobilization of intracellular calcium (e.g. 
Mirabet, Mallol, Lluis and Franco; 1997), have also been described. 
Actions of adenosine A2A receptors on neutrophil leukocytes are due in 
part to cAMP, but cyclic AMP-independent effects of A2A receptor 
activation in these cells have also been suggested. 
Activation of A1 receptors can dose and time dependently activate 
ERK1/2 via ,-subunits released from pertussis toxin-sensitive Gi/o 
proteins and phosphoinositol-3-kinase. 
Activation of A2A receptors also increases MAPK activity (Sexl, 
Mancusi, Holler, Gloria-Maercker, Schutz and Freissmuth; 1997) but the 
signaling pathways used by the A2A receptor seem to vary with the 
cellular background and the signaling machinery that the cell possesses 
(Seidel, Klinger, Freissmuth and Holler; 1999). A2A receptor activation 
may not only stimulate, but also inhibit ERK phosphorylation (Hirano, 
Aoki, Ogasawara, Kodama, Waga, Sakanaka, Shimizu and Nakamura; 
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1996, Arslan and Fredholm; 2000), probably via PKA-dependent 
phosphorylation of Raf-1. The adenosine A2B receptor is the only subtype 
that has so far been shown to activate not only ERK1/2, but also JNK and 
p38 perhaps via activation of  Gq/11, PLC, genistein-insensitive tyrosine 
kinases, ras, B-raf and MEK1/2 (Gao, Chen, Weber and Linden; 1999). 
Studies in transfected cells show a nearly 100-fold higher potency of both 
NECA and adenosine in inducing ERK1/2 phosphorylation than in 
inducing cAMP production. The EC50 value for ERK1/2 phosphorylation 
in transfected CHO lies in the nanomolar range, whereas cAMP 
production is half-maximally activated around 1-5 µM NECA. This 
emphasizes that G protein-coupled adenosine receptors can have 
substantially different potencies on different signaling pathways in the 
same cellular system. The adenosine A3 receptor activates ERK1/2 in 
human fetal astrocytes and in transfected CHO cells (Schulte and 
Fredholm; 2000).  
Adenosine A2A receptors in striatum interact with 
dopaminergic mechyanisms 
In 1974 Kjell Fuxe and Urban Ungerstedt showed that theophylline could 
by itself induce the same type of rotation-behavior that was induced by 
drugs that directly or indirectly stimulated dopamine receptors and that it 
could markedly enhance dopamine-mediated effects (Fuxe and 
Ungerstedt; 1974). In that study the effect was interpreted as secondary to 
blockade of phosphodiesterase (PDE) and was therefore taken as evidence 
for an important role of cyclic AMP as a mediator of dopamine actions. 
However, in a follow-up study where I (BF) was involved several 
different PDE inhibitors were examined and it was found that the potency 
of the drugs fitted much better with their potency as adenosine antagonists 
(or enhancers) than their potency as PDE inhibitors (Fredholm, Fuxe and 
Agnati; 1976). Together these studies showed that methylxanthines, 
probably by blocking adenosine receptors, could potentially be used as 
treatment in PD. 
Studies, in two laboratories, of dopamine stimulated adenylyl cyclase in 
brain also showed that methylxanthines could lower basal enzyme 
activity and that adenosine could stimulate it (Fredholm; 1977, Premont, 
Perez and Bockaert; 1977). This was observed in dopamine-rich areas of 
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the brain including caudate-putamen and tuberculum olfactorium, but not 
in other brain areas. This suggested that these parts of the brain might 
have a different set of adenosine receptors than other brain areas. 
This contention received support during the following decade as methods 
to study receptors using binding techniques were developed. The first 
studies used relatively non-selective radioligands but pharmacological 
means to discriminate between multiple binding sites Lee). Later studies 
used a rather selective ligand for A2A receptors, including CGS 21680, 
(Alexander and Reddington; 1989, Jarvis, Jackson and Williams; 1989, 
Jarvis, Schulz, Hutchison, Do, Sills and Williams; 1989, Parkinson and 
Fredholm; 1990).  Altogether these studies vindicated the belief that a 
special form of adenosine receptors, the A2A receptor, is enriched in 
dopamine rich areas of the brain and that this offers a rationale for 
examining the role of adenosine in mediating or modulating behaviours 
and traits traditionally associated with dopamine. 
The availability of more selective adenosine receptor agonists and 
antagonists also enforced the idea that behavioral consequences of 
adenosine-A2  and dopamine-receptor mediated effects tended to be 
opposite (Fredholm, Herrera-Marschitz, Jonzon, Lindström and 
Ungerstedt; 1983, Heffner, Wiley, Williams, Bruns, Coughenour and 
Downs; 1989, Brown, Gill, Evenden, Iversen and Richardson; 1991). 
The interactions between adenosine and dopamine receptors in striatum 
continued to be studied at the biochemical level. The A2A receptor being 
coupled to a member of the Gs family of G proteins, and the D2 receptor 
being coupled to a Gi protein would interact negatively at the level of 
second messengers and beyond. It was demonstrated that there were 
interactions between adenosine A2A receptors at several levels. Using 
binding it was found that high affinity binding of D2 agonists could be 
reduced by stimulation of adenosine A2A receptors (Ferré, von Euler, 
Johansson, Fredholm and Fuxe; 1991). This finding suggested that there 
were interactions directly between the receptors (Figure 2), an issue that 
has been forcefully pursued by Kjell Fuxe and his colleagues.  
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FIGURE 2. Schematic illustration of the interactions between adenosine and dopamine 
 
The next major conceptual advance was the cloning of several 
adenosine receptors, as described above. These findings not only 
conclusively proved that there are two distinct adenosine A2 receptors, but 
also provided a set of novel tools that proved very useful. In situ 
hybridisation was used to pinpoint the cells that express A2A receptors in 
the brain. Using increasingly sophisticated methods it was proven that the 
bulk of A2A expression is confined to one set of neurones in the striatum, 
namely those GABAergic output neurons that constitute the so-called 
indirect pathway (Schiffmann, Jacobs and Vanderhaeghen; 1991, 
Schiffmann, Libert, Vassart and Vanderhaeghen; 1991, Fink et al.; 1992, 
Johansson, Ahlberg, van der Ploeg, Brené, Lindefors, Persson and 
Fredholm; 1993, Pollack, Harrison, Wooten and Fink; 1993, Johansson, 
Georgiev and Fredholm; 1997, Svenningsson, Le Moine, Kull, Sunahara, 
Bloch and Fredholm; 1997). These cells also express the bulk of the 
dopamine D2 receptors. Hence the link between A2A and dopamine D2 
receptors was further strengthened. 
Techniques with a cellular resolution were also used to try to determine 
the roles of adenosine A2A receptors in the intact striatum. This was based 
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on early findings showing that expression of immediate early genes could 
be used to pinpoint changes in neuronal activity and/or signal 
transduction (Sheng and Greenberg; 1990). We observed that stimulatory 
doses of caffeine and selective A2A receptor antagonists caused a decrease 
in the expression of IEGs, known to be regulated by the cAMP/CREB 
cascade, in striatopallidal neurons (Svenningsson, Nomikos and 
Fredholm; 1995, Svenningsson, Nomikos, Ongini and Fredholm; 1997). 
These and subsequent studies  (Pinna, Wardas, Cozzolino and Morelli; 
1999, Chen, Moratalla, Impagnatiello, Grandy, Cuellar, Rubinstein, 
Beilstein, Hackett, Fink, Low, Ongini and Schwarzschild; 2001) provide 
strong evidence that adenosine, via A2A receptors, exert a robust tonic 
activation of the cAMP/CREB/IEG cascade in striatopallidal neurons. 
Moreover, this result also provided evidence that multiple D2 receptor-
mediated effects by dopamine can be attributed to an antagonism of this 
adenosine-mediated activation of striatopallidal neurons.  
In order to increase our understanding of the interactions of adenosine and 
dopamine at the signal transduction level, we proposed a collaborative 
project with Paul Greengard to study the effects of adenosine A2A 
selective compounds and caffeine on the phosphorylation of dopamine 
and cAMP phosphoprotein of 32 kDa (DARPP-32). DARPP-32 is highly 
enriched in all striatal GABAergic medium-sized projection neurons and 
is an important mediator of dopaminergic signaling (Greengard; 2001). Its 
function is determined by its relative phosphorylation state at several 
different threonine/serine residues, of which the most studied is a PKA-
site Thr34. When this residue is phosphorylated it converts DARPP-32 
into an inhibitor of protein phosphatase-1, which, in turn, regulates the 
activity of multiple transcription factors, including CREB, ion channels 
and ionotropic receptors (Fig 2). In initial studies conducted in brain 
slices prepared from striatum, it was found that CGS 21680 potently 
increases phosphorylation at Thr34 (Svenningsson, Lindskog, Rognoni, 
Fredholm, Greengard and Fisone; 1998). This effect was additive to that 
of SKF81297, a selective D1 agonist, and could be counteracted by 
quinpirole, a selective D2 agonist (Lindskog, Svenningsson, Fredholm, 
Greengard and Fisone; 1999). This result identified adenosine, via A2A 
receptors, as a key regulator of the phosphorylation state of DARPP-32 in 
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striatopallidal neurons. Subsequently, we developed a method to reliably 
detect DARPP-32 phosphorylation in vivo and could demonstrate that the 
A2A antagonist used, SCH 58261, significantly counteracted the increase 
in DARPP-32 phosphorylation that was observed following treatment 
with selective D2 receptor antagonists (Svenningsson, Lindskog, Ledent, 
Parmentier, Greengard, Fredholm and Fisone; 2000). Likewise, the ability 
of D2 antagonists to increase DARPP-32 phosphorylation was 
dramatically reduced in A2A receptor KO mice. These data therefore 
provided further support for the notion that adenosine acting on A2A 
receptors is an important mediator of establishing a basal cyclic AMP 
level, which is necessary for many effects of dopamines action via D2 
receptors. In order to address the involvement of DARPP-32 in the 
behavioural actions of caffeine and selective adenosine A2A receptor 
compounds, we administred such compounds to DARPP-32 KO and 
studied effects on locomotor behaviour. As expected from the 
biochemical data, it was found that the ability of CGS 21680 to induce 
hypolocomotion was attenuated in DARPP-32 KO mice (Lindskog, 
Svenningsson, Pozzi, Kim, Fienberg, Bibb, Fredholm, Nairn, Greengard 
and Fisone; 2002). Similarly, the ability of caffeine and SCH 58261 to 
induce hyperlocomotion was attenuated in DARPP-32 KO mice. In this 
paper, an additional effect of A2A receptors on DARPP-32 
phosphorylation was shown, namely that A2A agonism via cAMP-
dependent mechanisms increases the phosphorylation of Thr34-DARPP-
32, but decreases the phosphorylation at Thr75-DARPP-32. Conversely, 
caffeine and SCH 58261 increase phosphorylation at Thr75-DARPP-32. 
This site has recently been shown to be phosphorylated by Cdk5 and 
when this happens DARPP-32 is converted into an inhibitor of PKA. 
Thus, by increasing the phosphorylation of Thr75-DARRP-32, caffeine 
and selective A2A receptor antagonists will further increase the inhibition 
of PKA. This feed-forward mechanism, which is also utilized by D2 
receptor agonists, will therefore potentiate the inhibitory influence of 
adenosine on the cAMP/PKA/CREB/IEG signaling pathway in 
striatopallidal neurons (Fig 1d).  
 
A2A receptor antagonists and Parkinson´s disease  
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In parallell with the development of an increasingly clear understanding 
of the biochemical and molecular underpinning of the adenosine-
dopamine interactions there has been extensive work on the effectiveness 
of adenosine A2A antagonists in various experimental models of PD. It 
will carry too far to try to present these results. However, a recent study 
showed that A2A receptor antagonism could reduce not only symptoms of 
PD, but also the loss of dopamine neurons induced by MPTP (Chen, Xu, 
Petzer, Staal, Xu, Beilstein, Sonsalla, Castagnoli, Castagnoli Jr and 
Schwarzschild; 2001). Furthermore, it was shown that in fact persistent  
L-DOPA effects require A2A receptors (Fredduzzi, Moratalla, Monopoli, 
Cuellar, Xu, Ongini, Impagnatiello, Schwarzschild and Chen; 2002).  
Thus, over the years the concept that A2A and D2 receptors interact in such 
a way that A2A antagonists could prove to be useful in PD has developed 
strongly. There are however concerns. One  potential concern is related to 
tolerance. It is very well known that some actions of caffeine develop 
rapid tolerance (Fredholm, Bättig, Holmén, Nehlig and Zvartau; 1999, 
Svenningsson, Nomikos and Fredholm; 1999). However, caffeine effects 
in PD models do not (Xu, Xu, Chen and Schwarzschild; 2002), and there 
is also no tolerance to selective A2A antagonsts in models that show 
tolerance to caffeine (Halldner, Lozza, Lindström and Fredholm; 2000). 
Another, and perhaps more serious, concern is related to the fact that A2A 
receptors regulate other things than activity in striatopallidal neurons. It 
has long been known that adenosine regulates platelet activation (Haslam 
and Cusack; 1981), and now we know that A2A receptors are responsible 
for this (Ledent, Vaugeois, Schiffmann, Pedrazzini, El Yacoubi, 
Vanderhaeghen, Costentin, Heath, Vassart and Parmentier; 1997). 
Similarly A2A receptors are critically important in regulating neuttrophil 
leucocyte activity (Cronstein; 1994), and activity of macrophages.  Even 
more importantly A2A receptors do regulate inflammatory reactions in 
general (Ohta and Sitkovsky; 2001). Therefore, long-term blockade of 
adenosine A2A receptors might cause undesirable peripheral morbidity.  
A potential way to attack this problem was afforded when it was 
discovered that A2A receptors in striatum are coupled to Golf proteins 
(Kull et al.; 2000), whereas on platelets, neutrophils and lymphocytes Gs 
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mediates the A2A effects. If it proves possible to find agents that 
selectively affects A2A-Golf more selective drugs may be found. 
Physiology of adenosine A1 receptors as determined from studies 
using knock out mice 
Even though quite selective agonists and antagonists are available for 
adenosine A1 receptors (Fredholm, IJzerman, Jacobson, Klotz and 
Linden; 2001), and consequently much is known about their role in 
physiology and pathophysiology we embarked on a classical gene knock 
out strategy. The second coding exon was targeted as described  
(Johansson, Halldner, Dunwiddie, Masino, Poelchen, Giménez-Llort, 
Escorihuela, Fernández-Teruel, Wiesenfeld-Hallin, Xu, Hårdemark, 
Betsholtz, Herlenius and Fredholm; 2001) and experiments were 
conducted on littermates from matings of heterozygote animals (A1R +/-) 
with a mixed C57Bl6/129OlaHsd background. 
The offspring showed the expected frequency (1/4 A1R +/+; 2/4 A1R +/- 
and 1/4 A1R -/-). There were no clear differences in the growth and 
maturation over the first five months between genotypes (Johansson, 
Halldner, Dunwiddie, Masino, Poelchen, Giménez-Llort, Escorihuela, 
Fernández-Teruel, Wiesenfeld-Hallin, Xu, Hårdemark, Betsholtz, 
Herlenius and Fredholm; 2001), but subsequently +/- and, especially, -/- 
mice tended to die faster than their +/+ littermates (Giménez-Llort, 
Fernández-Teruel, Escorihuela, Fredholm, Tobena, Pekny and Johansson; 
2002). So far we have not observed any major differences in fertility 
between genotypes, even though there is evidence that the A1 receptor is 
involved in sperm capacitation. 
A1R +/- and -/- mice showed no gross behavioural abnormalities. 
However, their grip strength, as judged by the so called wire hanger test, 
was reduced (Giménez-Llort et al.; 2002). This was somewhat surprising 
given the evidence that methylxanthines in doses that predominantly 
affect adenosine receptors appear, if anything, to increase muscle 
strength. 
Although overall locomotor activity was unaltered in A1R -/- mice 
(Johansson, Halldner, Dunwiddie, Masino, Poelchen, Giménez-Llort, 
Escorihuela, Fernández-Teruel, Wiesenfeld-Hallin, Xu, Hårdemark, 
Betsholtz, Herlenius and Fredholm; 2001), we have found that the 
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increase in motor activity that accompanies transition from light to dark is 
reduced in the knockout mice (Giménez-Llort et al.; 2002). Surprisingly, 
A1R +/- mice were in this regard indistinguishable from wild-type 
animals. However, exploratory activity (assayed in the open field test and 
the hole-board) tended to be increased in the heterozygotes (Giménez-
Llort et al.; 2002). This would tally with the known stimulatory effect of 
methylxanthines, including caffeine (Fredholm, Bättig, Holmén, Nehlig 
and Zvartau; 1999).  
The A1R -/- showed increased anxiety using two commonly used tests, 
the elevated plus maze and the dark-light box (Giménez-Llort et al.; 
2002). This is interesting because hyperanxiety was also observed in A2A 
-/- mice (Ledent et al.; 1997). Future experiments will tell if the traits in 
the two strains is synergistic. It is also interesting to compare with the fact 
that high doses of caffeine that acts on A1 and A2A receptors produces 
anxiety in animals and man (Fredholm, Bättig, Holmén, Nehlig and 
Zvartau; 1999). Using the resident intruder test A1R -/- mice also 
exhibited increased aggressiveness (Giménez-Llort et al.; 2002), again a 
trait also observed in A2A -/- mice (Ledent et al.; 1997). By contrast, no 
effect was observed when examining memory functions with the Morris 
water maze. 
Using the hippocampal slice preparation the inhibitory adenosine effects 
were shown to be eliminated in A1R -/- mice (Johansson, Halldner, 
Dunwiddie, Masino, Poelchen, Giménez-Llort, Escorihuela, Fernández-
Teruel, Wiesenfeld-Hallin, Xu, Hårdemark, Betsholtz, Herlenius and 
Fredholm; 2001). This is an important finding since it shows that there are 
no important effects mediated via any of the other receptors in this 
preparation, despite the fact that important effects of both A2A  (Sebastiao 
and Ribeiro; 1996) and A3 receptors  (Dunwiddie, Diao, Kim, Jiang and 
Jacobson; 1997) has been reported. Another important finding was that 
the dose-response curve for adenosine was shifted significantly (two-fold) 
to the left in A1R +/- mice, which possess almost exactly half the normal 
number of receptors. This emphasises the important general point that 
potency of adenosine analogues is strongly dependent on the number of 
receptors. There were no adaptive changes in responses to GABAB 
receptor activation or any adaptive changes in A2A receptors.  
Home
Edition
This PDF created with the FREE RoboPDF Home Edition (not legal for business or government use)
Get RoboPDF: An Easy, Affordable Alternative for Creating PDFs - www.robopdf.com Buy RoboPDF
B. B. FREDHOLM  ANAL. REAL ACAD. NAL. FARM. 
 156 
 
Ever since the pioneering work of Berne and Gerlach a role for adenosine 
in mediating responses to hypoxia and ischemia has been postulated. We 
have so far examined the role of A1 receptors in two such responses. In 
the hippocampal slice preparation responses to hypoxia include a fast 
decrease in responses to excitatory stimulation. We found that virtually all 
of this decrease was lost in slices from A1R -/- mice (Johansson, 
Halldner, Dunwiddie, Masino, Poelchen, Giménez-Llort, Escorihuela, 
Fernández-Teruel, Wiesenfeld-Hallin, Xu, Hårdemark, Betsholtz, 
Herlenius and Fredholm; 2001). Furthermore, A1R -/- slices did not fully 
recover after hypoxia, as did A1R +/+ slices. These findings clearly 
demonstrate that adenosine acting on A1 receptors is critically important 
in regulating the responsiveness of neurons to decreased supply of 
metabolizable energy, enabling the neurons to survive such energy 
shortage.  
A somewhat similar effect was observed when activity of respiratory 
neurons in the immature brainstem was studied. The normal depression of 
rate of spontaneous firing induced by hypoxia was lost or markedly 
reduced in A1R -/- mice. Also in this preparation the recovery seen in 
A1R +/+ mice was less complete in A1R -/- brainstem neurons 
(Johansson, Halldner, Dunwiddie, Masino, Poelchen, Giménez-Llort, 
Escorihuela, Fernández-Teruel, Wiesenfeld-Hallin, Xu, Hårdemark, 
Betsholtz, Herlenius and Fredholm; 2001).  
Body temperature was similar in all genotypes, but the temperature 
lowering effect of adenosine analogues was less pronounced in A1R +/-, 
and, particularly, A1R -/- mice (Johansson, Halldner, Dunwiddie, Masino, 
Poelchen, Giménez-Llort, Escorihuela, Fernández-Teruel, Wiesenfeld-
Hallin, Xu, Hårdemark, Betsholtz, Herlenius and Fredholm; 2001). 
It has long been known that adenosine can control pain  (Sawynok and 
Sweeney; 1989) and adenosine receptors, particularly A1 receptors, have 
been known to be present in spinal cord (Geiger et al.; 1984, Fastbom, 
Post and Fredholm; 1990). It was therefore no major surprise when we 
found that the analgesic effects of intrathecal adenosine analogues were 
essentially lost in A1R -/- mice (Johansson, Halldner, Dunwiddie, 
Masino, Poelchen, Giménez-Llort, Escorihuela, Fernández-Teruel, 
Wiesenfeld-Hallin, Xu, Hårdemark, Betsholtz, Herlenius and Fredholm; 
Home
Edition
This PDF created with the FREE RoboPDF Home Edition (not legal for business or government use)
Get RoboPDF: An Easy, Affordable Alternative for Creating PDFs - www.robopdf.com Buy RoboPDF
VOL. 69 (4)  ADENOSINE RECEPTORS 
 
 
157 
2001). Somewhat more surprising was the finding that there was a clear 
hyperalgesia in these animals. This clearly suggests that adenosine acting 
at A1 receptors constitute a significant endogenous analgesic mechanism.  
The actions of adenosine are however mediated also by other adenosine 
receptors.  Thus adenosine A2A rerceptors, presumably located at sensory 
nerve endings, medate hyperalgesia (Ledent et al.; 1997). A3 receptors are 
 at least in mice  important as promoters of peripheral inflammation 
that leads to pain. 
It has long been known that adenosine can decrease cardiac performance 
and reduce heart rate (Drury and Szent-György; 1929), and this effect, 
which is clinically relevant, is linked to A1 receptors. The depressant 
effect of exogenous adenosine analogues was virtually eliminated in A1R 
-/- mice.  It was therefore surprising that heart rate in A1R -/- mice proved 
to be similar to that in their wild type littermates.  
Blood pressure in anaesthetised mice was elevated in the A1R -/- 
genotype (12 mm Hg), and there was even a tendency towards an elevated 
blood pressure in A1R +/- mice ( 5 mm Hg) (Brown, Ollerstam, 
Johansson, Skött, Fredholm and Persson; 2001).  Since A1R -/- mice also 
had an elevated level of plasma renin a possible explanation is that the 
blood pressure elevation is due to angiotensin. However, an antagonist 
did not differ in its blood pressure lowering effect between genotypes 
(Brown, Ollerstam, Johansson, Skött, Fredholm and Persson; 2001). 
There were no major differences in blood vessel reactivity between 
genotypes, so we are still looking for the cause of the blood pressure 
increase. Given that the A2AR -/- genotype is also hypertensive  (Ledent 
et al.; 1997) it will be interesting to know if the double knock-out shows a 
marked blood pressure elevation. 
In preliminary studies we have found that isolated hearts from A1R -/- 
mice do not differ in their response to acute ischemia from hearts from 
their wild type littermates. However, we do see a markedly reduced 
protective effect of remote preconditioning. Ongoing studies aims at 
demonstrating the underlying mechanisms. 
Sodium excretion was markedly (two-fold) elevated in both A1R +/- and -
/- mouse kidneys (Brown, Ollerstam, Johansson, Skött, Fredholm and 
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Persson; 2001). This agrees with the known effects of caffeine and other 
adenosine receptor antagonists. By contrast, potassium excretion and 
glomerular filtration rate was unaltered. Most importantly, 
tubuloglomerular feedback is completely eliminated in A1R -/- mice 
(Brown, Ollerstam, Johansson, Skött, Fredholm and Persson; 2001). 
These results emphasize that renal A1 receptors constitute important drug 
targets. 
Knock-out mice can be used not only to determine the role(s) of a 
particular gene product in physiology and pathophysiology, but also to 
determine the selectivity of drugs. So far we have finished a study that 
demonstrates that at least some of the effects of ATP (and other adenine 
nucleotides) in the hippocampus are in fact mediated by A1 receptors, 
since the responses are completely eliminated in A1R -/- mouse 
hippocampi. It will be important in the future to perform similar studies in 
other tissues, since adenine nucleotides are so very rapidly broken down 
at cell membranes generating high local concentrations of adenosine  
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